Clinical trial
A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer
NCT06218667
Study timeline
Study start (actual)2024-01-11Date precision: day
Registry last updated2024-10-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
CopanlisibDRUG · verified · RxNorm: copanlisib
DegarelixDRUG · verified · RxNorm: degarelix
Radical ProstatectomyPROCEDURE
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06218667 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.